Welcome to Department of Immunology

Department head: Professor Johanna Olweus
Department secretary: Anne Uhnger

Department of Immunology houses four research units:

Immunotherapy and Antigen presentation, headed by professor Johanna Olweus
Lymphomas and Lymphocyte biology, headed by professor Erlend B. Smeland
Molecular Medicine, headed by professor Mouldy Sioud
Immunotherapy, headed by professor Gustav Gaudernack

The group leaders are affiliated with the departments of Molecular Biosciences and Pharmacy at the University of Oslo, where they lecture at undergraduate and graduate courses. Supervision of graduate students and doctoral candidates takes place at the Department of Immunology. Several foreign research fellows and visiting scientists are also associated with the research teams.

Immunotherapy and Antigen presentation	Lymphomas & Lymphocyte biology	Molecular Medicine	Immunotherapy

Johanna Olweus	Erlend B. Smeland	Mouldy Sioud	G. Gaudernack

Contact information:
Department of Immunology, Institute for Cancer Research
Oslo University Hospital, Montebello, 0310 Oslo, Norway
Phone: +47 22 78 13 23 (Dept. secretary), +47 22 93 40 00 (switchboard),
Fax +47 22 78 13 24
Send mail to dept. secretary

Print this page [17604 visits]

Situated at:

Radiumhospitalet

News & events

Institute seminar March 10th 10.30
Gustav Gaudernack
Mar 9, 2010

Group at Institute for Cancer Research identifies new functional mechanism for a tumour suppressor
Mar 8, 2010

Molecular Genetics group publishes in Journal of Clinical Oncology
Mar 3, 2010

Institute seminar March 3rd 10.30
Kirsten Sandvig
Mar 1, 2010

Reminder:
21st Meeting of the European Association for Cancer Research, 26 - 29 June 2010
Feb 25, 2010

More news

Latest publications

Dept. of Immunology

Falster DS, Nakken S, Bergem-Ohr M, Rødland EA, Breivik J
Unstable DNA Repair Genes Shaped by Their Own Sequence Modifying Phenotypes
J Mol Evol (in press)
PubMed 20213140

Committee for Advanced Therapies (CAT), CAT Scientific Secretariat, Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Anc?ns J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS, Moraru AS, Turcáni P, Zorec R, Ruiz S, Akerblom L, Narayanan G, Kent A, Bignami F, Dickson JG, Niederwieser D, Figuerola-Santos MA, Reischl IG, Beuneu C, Georgiev R, Vassiliou M, Pychova A, Clausen M, Methuen T, Lucas S, Schüssler-Lenz M, Kokkas V, Buzás Z, MacAleenan N, Galli MC, Lin? A, Gulbinovic J, Berchem G, Fraczek M, Menezes-Ferreira M, Vilceanu N, Hrubisko M, Marinko P, Timón M, Cheng W, Crosbie GA, Meade N, di Paola ML, VandenDriessche T, Ljungman P, D'Apote L, Oliver-Diaz O, Büttel I, Celis P (2010)
Challenges with advanced therapy medicinal products and how to meet them
Nat Rev Drug Discov, 9 (3), 195-201
PubMed 20190786

Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T
Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
J Immunol Methods (in press)
PubMed 20171968